ssr订阅号

menu
  • Investors
  • Media Center
search
Follow Us
    • United States
    • Canada
解决国外网站很慢
加速国外网页加速软件

ssr订阅号

LEARN MORE

See more

ssr订阅号

We’re Horizon, a global biopharmaceutical company driven by a simple idea: we believe that science and compassion must work together to transform lives.

SEE MORE

ssr订阅号

Our pipeline is built on purpose, and our scientific courage drives us to tackle many marginalized, overlooked or forgotten diseases.

SEE MORE

ssr订阅号

At Horizon, we’re driven by a clear purpose; to improve patients’ lives. And the clearest expression of that purpose is the portfolio of medicines we offer to treat rare and rheumatic diseases.

SEE MORE

ssr订阅号

As a company, we condemn racism in all its abhorrent forms, including anti-Black racism and stand in solidarity with our Black colleagues and Black communities around the country. Read our statement here.

SEE MORE

ssr订阅号

07/31/2020 New Topline TEPEZZA® (teprotumumab-trbw) Data Underscore its Efficacy in Longer Disease Duration, Long-Term Durability and Potential for Retreatment in People Living with Thyroid Eye Disease (TED) 07/22/2020 Target Enrollment Reached in MIRROR Randomized Controlled Trial Evaluating KRYSTEXXA® (pegloticase injection) Co-Prescribed with Methotrexate as an Immunomodulator to Enhance Response Rates for People Living with Uncontrolled Gout
SEE MORE